| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/22/2010 | WO2010082690A1 Postprandial hyperglycemia-improving agent |
| 07/22/2010 | WO2010082661A1 1,5-ag-containing composition |
| 07/22/2010 | WO2010082601A1 Novel 2,5-disubstituted pyrrole derivative |
| 07/22/2010 | WO2010082390A1 Low-concentration nutritional composition |
| 07/22/2010 | WO2010082072A1 Process for the preparation of rosuvastatin salts |
| 07/22/2010 | WO2010081862A2 Methods and preparations for protecting critically ill patients |
| 07/22/2010 | WO2010081264A1 Pharmaceutical composition for preventing and treating diabetic nephropathy and preparation method thereof |
| 07/22/2010 | WO2010081263A1 A pharmaceutical composition for treating diabetic nephropathy and the preparation method and use thereof |
| 07/22/2010 | WO2010081262A1 A pharmaceutical composition for treating diabetic nephropathy and the preparation method and use thereof |
| 07/22/2010 | WO2010081259A1 A composition comprising extraction of fucoxanthin |
| 07/22/2010 | WO2010045623A9 Irvingia gabonensis to treat and prevent metabolic syndrome and reduce total cholesterol, ldl cholesterol, blood glucose, c-reactive protein, and leptin levels and increasing increasing adiponectin levels |
| 07/22/2010 | WO2010045563A3 Combination therapies for the treatment of obesity |
| 07/22/2010 | WO2010045522A3 Combination therapies for the treatment of obesity |
| 07/22/2010 | WO2010040055A3 Oral pharmaceutical formulations for antidiabetic compounds |
| 07/22/2010 | WO2010007046A3 Heteroaryl derivatives as dgat1 inhibitors |
| 07/22/2010 | WO2009080198A8 Fused cynopryridines and the use thereof |
| 07/22/2010 | US20100184868 Fortification of nutritional products with olive extracts containing hydroxytyrosol and hydroxytyrosol fortified nutritional products. |
| 07/22/2010 | US20100184865 Use Of RR/SR-Ractopamine |
| 07/22/2010 | US20100184864 Composite Material and Method for Production Thereof |
| 07/22/2010 | US20100184850 Phenolic extracts of almond peel containing procyanidins, propelargonidins, and prodelphinidins, and method for preparation thereof |
| 07/22/2010 | US20100184829 Rnai modulation of scap and therapeutic uses thereof |
| 07/22/2010 | US20100184825 for treating, preventing, inhibiting, or reducing obesity, insulin resistance, diabetes and any other disease, trait, or condition that is related to or will respond to the levels of PTP-1B in a cell or tissue |
| 07/22/2010 | US20100184813 Chemical compounds 553 |
| 07/22/2010 | US20100184809 Heterocyclic FXR Binding Compounds |
| 07/22/2010 | US20100184802 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof |
| 07/22/2010 | US20100184799 Oxadiazole beta carboline derivatives as antidiabetic compounds |
| 07/22/2010 | US20100184794 Fused heterocyclic compound |
| 07/22/2010 | US20100184791 Compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 07/22/2010 | US20100184786 Polar Quinazolines |
| 07/22/2010 | US20100184783 Combination for use in the treatment of inflammatory atherosclerosis comprising a mast cell inhibitor and a ppar gamma agonist |
| 07/22/2010 | US20100184777 Substituted Pyrazinone Amides |
| 07/22/2010 | US20100184776 Piperidine/piperazine derivatives |
| 07/22/2010 | US20100184774 Methods of treatment |
| 07/22/2010 | US20100184772 Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators |
| 07/22/2010 | US20100184763 Quinolone based compounds exhibiting, prolyl hydroxylase inhibitory activity, and compositions, and uses thereof |
| 07/22/2010 | US20100184759 Pyrano-pyrazole-amines |
| 07/22/2010 | US20100184758 Beta carboline derivatives as antidiabetic compounds |
| 07/22/2010 | US20100184749 Benzothiadiazine compounds and their use |
| 07/22/2010 | US20100184739 Modulators of ATP-Binding Cassette Transporters |
| 07/22/2010 | US20100184734 Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy |
| 07/22/2010 | US20100184730 Fatty Acid Acylated Salicylates and Their Uses |
| 07/22/2010 | US20100184717 Treatment of Statin Side Effects Using Uridine Derivatives |
| 07/22/2010 | US20100184708 Use of gly-pro-glu-oh (gpe) as a therapeutic agent |
| 07/22/2010 | US20100184698 Use of a deslorelin and mastoparan as a therapeutic agent |
| 07/22/2010 | US20100184690 Combined Use Of A GLP-1 Compound And A Modulator Of Diabetic Late Complications |
| 07/22/2010 | US20100184687 Purification of Glucagon-Like Peptides |
| 07/22/2010 | US20100184680 Therapeutic uses of b-type natriuretic peptide and human growth hormone 1-43 |
| 07/22/2010 | US20100184679 Use of a combination of cart peptides as a therapeutic agent |
| 07/22/2010 | US20100184678 Use of a peptide as a therapeutic agent |
| 07/22/2010 | US20100184677 Use of the human pancreatic polypeptide as a therapeutic agent |
| 07/22/2010 | US20100184675 Use of glucagon (1-29) alone or in combination with neuropeptide w30 as a therapeutic agent |
| 07/22/2010 | US20100184674 Proadrenomedullin alone or in combination with big gastrin i as a therapeutic agent |
| 07/22/2010 | US20100184673 Use of parathyroid hormone ( 1-34 ) as anti-hiv agent |
| 07/22/2010 | US20100184666 Novel use of cocoa extract |
| 07/22/2010 | US20100184665 Method for activating receptor by cofactor and method for utilizing ligand activity |
| 07/22/2010 | US20100184660 Single exon genes encoding for novel bio-active peptides |
| 07/22/2010 | US20100184659 Sustained-Release Formulations Comprising Crystals, Macromolecular Gels, and Particulate Suspensions of Biologic Agents |
| 07/22/2010 | US20100184646 Melanocortin receptor ligands modified with hydantoin |
| 07/22/2010 | US20100184642 Transgenic Plants Expressing Cobalamin Binding Proteins |
| 07/22/2010 | US20100184641 Novel Plasma Protein Affinity Tags |
| 07/22/2010 | US20100184640 Dog diabetes |
| 07/22/2010 | US20100184636 Method of Regulating Mammalian Target-of-Rapamycin Activity by Interaction Between Phospholipase D and Raptor |
| 07/22/2010 | US20100183736 Rehydration beverage |
| 07/22/2010 | US20100183732 Novel one step process for preparing cross-linked poly(allylamine) polymers |
| 07/22/2010 | US20100183713 Gastrointestinal-specific multiple drug release system |
| 07/22/2010 | US20100183712 Acylated indanyl amines and their use as pharmaceuticals |
| 07/22/2010 | US20100183700 Implantable pump for protein delivery for obesity control by drug infusion into the brain |
| 07/22/2010 | US20100183632 Antibody Therapy For Modulating Function Of Intestinal Receptors |
| 07/22/2010 | US20100183626 Human phospholipase a2 epsilon |
| 07/22/2010 | US20100183624 Methods for increasing adiponectin |
| 07/22/2010 | US20100183612 Methods of treatment using ctla4 mutant molecules |
| 07/22/2010 | US20100183597 Drak2 expression is associated with diabetes |
| 07/22/2010 | US20100183592 Human epo receptor agonists, compositions, methods and uses for preventing or treating glucose intolerance related conditions |
| 07/22/2010 | US20100183588 Mutated Netrin-4, Fragments Thereof And Their Use As Medicines |
| 07/22/2010 | US20100183580 Treatment of pigs for reducing the feed conversion ratio or increasing the growth rate |
| 07/22/2010 | DE102009005201A1 Verwendung von Polyphenol-haltigen Pflanzenextrakten zur Behandlung von Adipositas und Diabetes mellitus Typ 2 Use of polyphenol-containing plant extracts for the treatment of obesity and type 2 diabetes mellitus |
| 07/22/2010 | DE102009005193A1 Neue heterocyclische Verbindungen als MetAP-2 Inhibitoren New heterocyclic compounds as MetAP-2 inhibitors |
| 07/22/2010 | CA2749727A1 Process for the preparation of rosuvastatin salts |
| 07/22/2010 | CA2749544A1 Methods for increasing adiponectin |
| 07/22/2010 | CA2749424A1 Method of treating cancer |
| 07/22/2010 | CA2749401A1 Low-concentration nutritional composition |
| 07/22/2010 | CA2749195A1 Protein kinase c inhibitors and uses thereof |
| 07/22/2010 | CA2749005A1 Companion animal compositions including pyruvic acid and salts thereof and methods of use thereof |
| 07/21/2010 | EP2208728A1 Heterocyclic derivative having inhibitory activity on type-i 11 -hydroxysteroid dehydrogenase |
| 07/21/2010 | EP2208727A1 Diaryl ethers as opioid receptor antagonist |
| 07/21/2010 | EP2208495A1 Cyanoguanidine-based azole compounds useful as malonyl-CoA decarboxylase inhibitors |
| 07/21/2010 | EP2208422A1 Compositions and methods for reducing or preventing obesity |
| 07/21/2010 | EP2207775A1 4-benzylamino-1-carboxyacyl-piperidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis |
| 07/21/2010 | EP2207774A1 Triazole derivatives as scd inhibitors |
| 07/21/2010 | EP2207770A1 1, 2, 3-triazole derivatives for use as stearoyl-coa desaturase inhibitors |
| 07/21/2010 | EP2207766A1 Novel sulfamate compounds for medical use |
| 07/21/2010 | EP2207560A2 Use of fibronectin fragment (196-203) as a therapeutic agent |
| 07/21/2010 | EP2207420A1 Anti-glycation methods and compositions |
| 07/21/2010 | EP1750523B1 Compositions and methods for reducing or preventing obesity |
| 07/21/2010 | EP1706128B1 Pharmaceutical compositions and methods for insulin treatment |
| 07/21/2010 | EP1610789B1 Bicyclic piperidine derivatives as melanocortin-4 receptor agonists |
| 07/21/2010 | EP1487444B9 Use of pyridyl amides as inhibitors of angiogenesis |
| 07/21/2010 | EP1444516B1 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment |
| 07/21/2010 | EP1399445B9 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists |
| 07/21/2010 | EP1079825B1 Compounds that inhibit the binding of integrins to their receptors |